secwatch.observer — SEC 8-K summary
======================================

Issuer:     IBEX Ltd (IBEX)
CIK:        0001720420
Form:       8-K
Filed at:   2025-02-06T23:59:59+00:00
Accession:  0001720420-25-000008
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IBEX Q2 revenue $140.7M (+6.1% YoY); raises FY guidance; adjusted EPS $0.59
---------------------------------------------------------------------------

- Q2 revenue $140.7M (+6.1% YoY); net income $9.3M (+52.6%); diluted EPS $0.57 vs $0.33 a year ago.
- Adjusted EPS $0.59 (+36% YoY); adjusted EBITDA $16.5M (+15.4%); margin 11.8% vs 10.8%.
- Raised FY2025 revenue guidance to $525-535M (from $515-525M); adjusted EBITDA guidance $68-69M.
- Repurchased 3.6M shares from TRGI for $70M, eliminating controlled company status.
- HealthTech (+31.2%) and Travel/T&L (+16.7%) drove growth; FinTech declined 14.7%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1720420/000172042025000008/0001720420-25-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1720420/000172042025000008/ibex-20250206.htm
  HTML page:      https://secwatch.observer/filing/0001720420-25-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer